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T 
HERE are  nearly 50 different intermediate filament 
(IF)  proteins  of five major types  (for reviews,  see 
references 16, 23, and 59). Four of the IF types are cy- 
toplasrnic, and they are expressed differentially  in all tissues 
at various stages of embryonic and adult development. Type 
V IF proteins are the nuclear lamins, which form a fibrous 
meshwork on the inner surface of the nuclear membrane, 
and they are universally expressed in higher eukaryotes. Al- 
though the functions of cytoplasmic IFs remain largely un- 
known, defects in the genes encoding these proteins have 
been  shown to  give rise  to  autosomal dominant,  tissue- 
specific degenerative disorders. This article reviews how a 
knowledge of IF  mutations in  disease has  advanced our 
knowledge of IF structure, and how the clinical features of 
IF diseases have, in turn, enhanced our understanding of the 
roles of IFs in higher eukaryotic organisms. 
IF Assembly: A Lesson in Protein Design 
IF proteins share common structural features enabling them 
to self assemble into complex 10-nm filaments in vitro in the 
absence of  auxiliary proteins or factors (Fig. 1). IFs are rope- 
like structures made of *4.5-nm protofibrils, which in turn 
are made from smaller fibers called protofilaments (2). Pro- 
tofilaments contain linear arrays of IF dimer subunits, ar- 
ranged in head to tail fashion (1, 31). Although the molecular 
details of  protofilaments have not yet been precisely defined, 
each protofilament appears to be constructed from two an- 
tiparallel chains of these dimers. 
The IF dimer is a coiled coil of two in-register molecules 
aligned in a parallel fashion. Cytoskeletal IF proteins have 
a central 310--amino acid residue a-helical domain, the rod, 
which is flanked by nonhelical head (amino end), and tail 
(carboxy end) domains. The formation of the coiled coil is 
guided by heptad repeats of hydrophobic amino acids within 
the rod. This feature has been widely used in nature to facili- 
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tate interactions between two or more proteins.  Most IF 
types are able to form homodimers. Keratins are unusual in 
that they form obligatory heterodimers of a type I and a type 
II subunit. 
In solution, stable tetramers form from two dimers ar- 
ranged in an unparallel fashion, either in an unstaggered 
alignment or in a  near half-staggered alignment with an 
amino terminal overlap (for review see reference 23). Chem- 
ical cross-linking data support the existence of both forms 
in IFs (25, 56, 57). It has been postulated that the staggered 
alignments occur at the level of the protofilament; i.e., in 
alignment of the two antiparallel linear arrays of dimers 
(which could also be viewed as end-to-end linkages of stag- 
gered tetramers). The unstaggered alignments may be used 
during higher ordered lateral interactions, perhaps between 
protofibrils (30). 
Further insights into the molecular associations in IFs 
have been gained by secondary structure analyses, sequence 
comparisons,  and molecular mutagenesis of IF  subunits. 
The IF a-helical rod is subdivided by three short nonhelical 
linker segments, L1, L1-2, and L2 (Fig. 1, thin lines). These 
segments often contain proline or multiple glycine residues, 
and they are predicted to break the a-helical rod at locations 
that are conserved among all IF proteins (16, 27). The four 
resulting rod segments are referred to as helices 1A, 2A, 1B, 
and 2B. The sequence identity among all IF proteins is par- 
ticularly high at the start of  helix 1A and near the end of  helix 
213, making these domains the most diagnostic for an IF pro- 
tein. Deletion mutagenesis studies indicate that the ends of 
the rod play a special role in IF assembly (3, 19, 26, 51, 68). 
Even subtle point mutations in these highly conserved se- 
quences can have deleterious effects  (28,  29,  41)  that are 
more severe than proline mutations more centrally in the rod 
(41). It has recently been postulated that in the linear, head- 
to-tail arrays of dimers, the rod ends of one dimer may over- 
lap slightly with the rod ends of an adjacent dimer, thereby 
accounting for their special importance in IF structure (30, 
56; Fig.  1). 
Despite extensive mutagenesis studies, the functions of  the 
nonhelical head and tail segments of IF proteins remain un- 
resolved. These domains vary greatly in length ("-,10--1,500 
residues) and amino acid composition, making it doubtful 
that the heads and tails of IFs produce a common structure. 
Indeed, deletion analyses of  tail segments are suggestive that 
much of this portion of IF proteins is often dispensable to 
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Figure I.  Model of IF struc- 
ture and correlation between 
mutation location and disease 
severity in  genetic  disorders 
of  keratin.  (Top) Model  is 
adapted from those described 
recently (25, 56, 57; particu- 
larly reference 30). Box, rod 
segments of a dimer;  arrow, 
direction of  polypeptides from 
base  (NH2 terminus)  to  tip 
(COOH  terminus);  hatched 
boxes, the  highly  conserved 
ends  of  helix  1A  and  2B, 
which  in  the  diagram  are 
shown as overlapping, as sug- 
gested by Steinert et al. (57). 
Note:  in this model,  unstag- 
gered antiparallel alignments 
of dimers arise at the level of 
protofibril-protofibril associa- 
tions (30). Small black bar in 
each arrow, the carboxy end 
of L1-2. (Bottom) Correlation 
between  mutation  location 
and disease severity in genetic 
disorders  of  keratin.  Stick 
figures,  secondary structures 
of human type H and type I keratins (27). Large boxes encompass the a-helical  rod domain, interrupted by the short nonhelical linker 
segments. Hatched boxes, conserved ends of the rod. Thinner bars denote nonhelical head and tail domains, with the H1 domain unique 
to type II keratins (16, 57) shown as a solid bar. Solid arrowheads, positions of mutations found in patients with severe EBS (K5 and K14) 
or EH (K1 and K10); open arrowheads, mutations in EPPK (K9); vertical bars, K-EBS mutations; solid dots, W-C EBS mutations; open 
dot, rare case of recessive EBS. Note: the preponderance of mutations in the carboxy half of the L1-2 linker segment leads to the postulate 
that this region may be directly opposite the putative rod end overlap in an adjacent dimer. 
IF structure, although some studies suggest that tails may 
play a role in governing lateral associations at the protofila- 
ment and protofibril level (30,  36,  39, 43). In contrast, IF 
head domains have more prominent and diverse roles in fila- 
ment structure, and roles in both lateral and end-to-end link- 
ages have been proposed (26, 30, 36, 57, 68). It is also likely 
that at least a portion of the head and/or taft segments pro- 
trude along the IF surface, wrapping the filament in a cloak 
of tissue-specific sequences. 
Finally, sequences in the head and tail are sites for phos- 
phorylation, which can orchestrate dyoamic IF assembly 
and disassembly events in vivo. Thus, mitosis-mediated re- 
organization  of vimentin  filaments  occurs  concomitantly 
with a transient increase in IF protein phosphorylation, and 
a cell cycle-dependent increase in phosphorylation of the la- 
rains coincides with nuclear lamina disassembly (for review 
see  reference 47).  Both  of these  in  vivo  processes  are 
governed by cdc2 kinase-mediated phosphorylation of tail 
and/or head sequences that immediately flank the IF rod do- 
main. The changes to IF assembly/function that accompany 
tail or head phosphorylations may extend beyond cell cy- 
cle-mediated changes in IF networks, and may range from 
modulation of surface properties of filaments (32) to influ- 
encing axonal caliber of neurofilaments (NFs), and possibly 
slowing axonal transport (for review, see reference 65). 
Genetic Diseases of  Keratin IFs and Refinements 
on IF Structure 
In contrast to microfilaments, microtubules, or the nuclear 
lamina,  cytoplasmic IFs seem to be dispensable for cells 
growing on a plastic surface in tissue culture. Thus, if nature 
had a purpose in mind for IFs, it must be to perform func- 
tions tailored to suit specialized needs of eukaryotic cells 
within their natural environment. It seems reasonable to sur- 
mise that compromising such functions could lead to human 
diseases whose phenotypes are confined to specific tissues. 
Since genetically engineered mutations in IF genes typically 
act in a dominant negative fashion to perturb cytoskeletal ar- 
chitectures,  candidate diseases  should be primarily auto- 
somal dominant. 
Epidermolysis bullosa simplex (EBS) is the first group of 
diseases discovered to be IF disorders. Affecting '~1:50,000 
in the population and with clinical features present at birth, 
EBS  is  characterized by  mechanical  stress-induced  skin 
blistering caused by cytolysis within the basal layer of the 
epidermis (see Fig. 2). The disease is typically transmitted 
in an autosomal dominant fashion, although recessive in- 
beritance has been reported. There are three major types of 
EBS:  (a) Dowling-Meara (D-M)  EBS is characterized by 
generalized, severe intraepidermal blistering and clumping 
of often afilamentous keratin within the basal cell cytoplasm 
(4); (b) Koebner (K) EBS is intermediate in severity; and (c) 
Weber-Cockayne (W-C) EBS patients have mild basal cell 
cytolysis and blistering predominantly on the hands and feet, 
and the basal keratin filaments often appear nearly normal, 
with occasionally only mild aggregation of filaments. In all 
EBS types, suprabasal layers are unperturbed, reflective of 
a normal differentiation process. 
From electron microscopy studies,  it was  noted that in 
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ner in disorders of IF proteins. Shown is a schematic of the stages 
of terminal differentiation in the epidermis. Only the innermost 
(i.e., basal) epidermal layer has the capacity for DNA synthesis. 
This layer synthesizes K5 and K14. Upon commitment to termi- 
nally differentiate and move outward towards the skin surface, a 
spinous cell remains transcriptionally active, but switches  to the ex- 
pression of K1 and K10. In EBS, basal cells express mutant K5 or 
KI4 proteins, which produce aberrant 10-nm filaments. This leads 
to cell degeneration upon mechanical  trauma in the basal cells, pre- 
sumably because the mechanical strength of these cells has been 
compromised. In EH, cells express mutant K1 or KIO proteins, 
generating aberrant IFs and cell fragility in the suprahasal cells. 
D-M EBS, tonofilament clumping exists even in cells that 
have not undergone lysis, hinting that anomalies in keratin 
networks may be early events in the blistering process (4). 
Additionally, cultured D-M EBS keratinocytes display per- 
turbed keratin networks, resembling those of normal ker- 
atinocytes transfected with a gene encoding a mutant basal 
type I keratin, K14 (37, 64). Most notably, transgenic mice 
engineered to express a truncated human K14, missing the 
tail and about one third of the a-helical rod segment, ex- 
hibited nearly all the symptoms of D-M EBS (64),  while 
transgenic mice expressing a  less severely disrupting K14 
mutant displayed features of W-C EBS (21). Thus, structural 
defects in K14 (and presumably its partner, type II keratin, 
KS) genes could generate EBS in mice, and the degree of 
blistering correlated with the degree to which the mutant 
keratin perturbed filament assembly in vitro. 
Subsequent to these studies, it was discovered that humans 
with EBS have point mutations in their K14 or K5 genes 
(8-10,  20, 22, 33, 34, 40, 55, 58). Fig. 1 summarizes the lo- 
cations of these mutations. The most severe EBS cases ana- 
lyzed (i.e.,  D-M)  have  a  single amino acid  substitution, 
125R:C/H, in a highly conserved residue in the amino end 
of  helix 1A of the K14 a-helical rod (Fig. 1 B, cluster of  solid 
arrowheads;  references 20,  58).  Affected members of an- 
other D-M EBS family have a 475E:G mutation in a con- 
served residue in the carboxy end of helix 2B of the K5 rod 
(40). Thus far, K-EBS mutations are located more centrally 
in the or-helical segments of the rod (Fig. 1 B, solid vertical 
bars; references 8,  11, 22), while W-C mutations are clus- 
tered either in the head domain of K5 or in the carboxy half 
of the linker L1-2 segment (Fig.  1 B, solid dots; references 
9,  10,  55;  see  also  34).  These  mutations correlate with 
affected individuals, and they have not been found in un- 
affected family  members or the normal population. Moreover, 
the genetic defects of EBS families map to human chromo- 
somes 17 or 12 (8-10), at locations corresponding to the loci 
for epidermal type I and type II keratin gene clusters, respec- 
tively (53 and references therein). 
Within the past 2 yr, a second autosomal dominant disease 
has been found to be an IF disorder. Like EBS, epidermo- 
lytic hyperkeratosis (EH) is typified by epidermal cytolysis, 
but in this case, the basal epidermal layer has normal mor- 
phology, and the cytolysis occurs in suprabasal layers (Fig. 
2; for review, see reference 4). In severe cases, tonofilament 
clumping and perinuclear shells of tonofilament aggregates 
are found in suprabasal cells, and there is a markedly thick- 
ened granular layer and stratum corneum in EH skin. Given 
the striking similarities between EBS and EH and the knowl- 
edge that epidermal cells switch to the expression of  K1 (type 
ID and K10 (type I) keratins as they commit to terminally 
differentiate, it was predicted that EH might be a disorder of 
K1 and KI0 (64).  This was later confirmed by transgenic 
mouse studies (24), by genetic mapping of  an EH family (15) 
and by sequence analyses of the K1 and K10 genes of EH pa- 
tients (12, 13, 54; see also 14, 44, 60, 69). Recently, yet an- 
other  disease,  epidermolytic  palmoplantar  keratoderma 
(EPPK) has been found to be a keratin disorder (52,  62). 
EPPK  is  similar to  EH,  but with blistering localized to 
suprabasal layers of palmoplantar skin. The gene often mu- 
tated in EPPK encodes K9, a type I keratin whose pattern 
of expression mirrors the blistering. 
As shown in Fig. 1, many of the same principles that oper- 
ate on the locations of K5 and K14 mutations in the various 
grades of EBS also apply to K1 and K10 mutations in EH 
and K9 mutations in EPPK. Remarkably, the arginine mu- 
tated in the K14 gene of D-M EBS (R125) is often mutated 
in the K10 gene of patients with severe EH and the K9 gene 
of patients with EPPK (12, 52, 54, 60). Thus, the same mu- 
tation in a highly conserved residue of three genes can give 
rise to three distinct genetic diseases by virtue of  the differen- 
tial expression of the genes. The high frequency with which 
this residue is mutated to a cysteine or a histidine in EBS, 
EH, and EPPK is partly caused by the fact that this residue 
is a hot spot for C to T mutagenesis by CpG methylation  and 
deamination (17). However, for both EBS and EH, mutations 
tend to be clustered and are frequently at the same or equiva- 
lent residues, even when they are not obvious hot spots for 
mutagenesis. 
In cases where genetic arguments cannot account for a 
high frequency of mutation of a particular residue, a com- 
promise of function is likely to be the underlying explana- 
tion.  Indeed, the overriding feature of the EBS,  EH,  and 
EPPK mutations is that they are critical for IF structure (10, 
12, 13, 20, 29, 42, 60). In this regard, structural studies on 
EBS mutations have revealed a correlation between the de- 
gree to which a mutation perturbs IF assembly, the specific 
location of a mutation, and the severity of the EBS or EH 
disease (42).  Such studies have chiseled new details into a 
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tering of severe mutations in the rod ends and to account for 
why these mutations primarily affect filament elongation in 
vitro (20), it has been proposed that the rod ends of end-to- 
end linked dimers may overlap slightly (56,  57), a feature 
that also explains repeat lengths in paracrystalline IF struc- 
ture (30). 
In contrast to the filament-shortening keratin mutations of 
severe EBS or EH, the L1-2 linker mutants ofW-C EBS pro- 
duce filaments in vitro that are unraveled, suggesting that 
lateral interactions may be affected (10). How might the L1-2 
linker segment play a  role in lateral interactions? Intrigu- 
ingly, chemical cross-linking data predict that two staggered 
dimers are aligned so that the carboxy half of the L1-2 do- 
main in one dimer is in close proximity to, and possibly even 
directly opposite, the helix 1A segment in an adjacent dimer 
(25, 56, 57). While these values are only accurate to 1 to '~10 
residues (25), when considered in conjunction with the puta- 
tive overlap of the ends of two linearly aligned dimers (57), 
it is possible that the rod ends and the L1-2 sequences all 
reside at a common junction. In such a model, the L1-2 seg- 
ment would play a clear role in the lateral alignment of stag- 
gered dimers. While more refined analyses will be necessary 
to unequivocally establish this alignment, perturbations at 
this  level  could  readily  influence  lateral  associations  at 
higher levels of IF structure (10). 
The fourth region where mutations are clustered is the H1 
domain of the head of the type II keratins (9,  13, 69).  The 
concentration of mutations in this region underscores its im- 
portance to IF  structure.  These  studies also  substantiate 
previous conclusions from in vitro assembly (67) and com- 
puter studies (16; see also 57) that this region of the head do- 
main of  type II keratins plays a role in IF assembly. Precisely 
how the head domain is  involved is  presently unknown. 
However,  in other IF types, this general region serves as a 
regulatory domain for phosphorylation-dependent  control of 
IF assembly. In this regard, it is intriguing that in two un- 
related W-C EBS families, the mutation is I161:S, creating 
a potential protein kinase C site (9). Whether this site is actu- 
ally phosphorylated in W-C EBS remains to be determined. 
IF Disorders in General 
The knowledge that EBS, EH, and EPPK are disorders of 
keratins has enabled predictions of other human genetic dis- 
eases that may be disorders of IF genes. In general, IF dis- 
eases are expected to be autosomal dominant, given the mul- 
timeric nature of IFs and the dominant negative action of 
most IF mutants. In addition, IF diseases are expected to dis- 
play perturbations in the IF networks, as well as subsequent 
degeneration and cytolysis in cells in which the IF gene is 
expressed. 
Several possible candidate hair diseases share these fea- 
tures (for review see reference 4). The autosomal dominant 
mouse mutants, Re, Bsk, and Re  ~n, map in close proximity 
to the type I  epidermal keratin genes (45  and references 
therein): Rex mice have curly whiskers and bent hair shafts, 
and denuded mutant mice and bareskin mice undergo hair 
loss after completion of the first hair cycle. Another class 
of candidate IF disorders are those that might involve NF 
genes. Although not present in all neurons, NFs are preferen- 
tially located in the axon, where they are thought to provide 
mechanical strength. Recently, Ohara et al. (48) discovered 
that the Quv mutant of Japanese quail is a recessive, non- 
sense mutation in the NF-L gene resulting in the absence of 
NF-L, a dramatic deficiency of NFs, a reduction in the cali- 
ber of  resulting axons, and a mild, generaliTed quivering. NF 
defects have also been suspected in the pathogenesis of sev- 
eral  types of neurodegenerative diseases,  such as  amyo- 
trophic lateral sclerosis or ALS and infantile spinal muscular 
atrophy (66 and references therein). Interestingly, transgenic 
mice that overexpress wild-type NFs or produce mutant NFs 
exhibit the hallmarks of motor neuron disease, including ax- 
onal  degeneration and  skeletal muscle  atrophy  (18, 70). 
Thus, present studies on the relation between NF aberran- 
ties and motor neuron diseases are promising, and future 
studies should reveal if such human diseases involve defects 
in NF genes. 
Other potential IF diseases include some forms of famil- 
ial cardiomyopathies. Many of these disorders are myosin 
defects (61). However, some are not, and in several of these 
cases, abnormalities in desmin filament networks have been 
observed electron microscopically (49).  Hence,  although 
human studies have not yet been conducted, it seems possi- 
ble that some of these cases may turn out to result from des- 
min mutations. 
How Do IF Mutations Cause Cell Lysis? 
A number of findings point to the hypothesis that without a 
proper IF network, cells become fragile and prone to break- 
age upon mechanical stress. Thus, in mice and humans, EBS 
cells often rupture in a defined zone beneath the nucleus and 
above the hemidesmosomes. This is the longest portion of 
the columnar basal cell, and the zone expected to be most 
fragile when mutations arise that compromise filament elon- 
gation, as do many of the EBS, EH, and EPPK mutations. 
Hence, an important function of keratin filaments seems to 
be to impart a mechanical framework to an epidermal cell. 
Do other IFs also play a role as mechanical integrators of 
space as suggested many years ago? Several lines of evidence 
suggest that they do. Treatment of female rats with anabolic 
steroids increases the number of  IFs in heart muscle, perhaps 
providing the heart strengthening sought after by atkletes 
(7).  In addition, theologic studies show that type []  IFs 
harden and resist breakage under stresses where other cyto- 
skeletal networks will rupture (35).  Conversely, a Xenopus 
oocyte extract depleted of its single lamin (Lm) is able to 
encapsulate chromatin by fused membrane vesicles and as- 
semble nuclear pores,  but the resulting nuclei are fragile 
(46). Similarly, transgenic mice overexpressing a wild-type 
hair keratin gene have cortical cells that are fragile, leading 
to brittleness and hair breakage (50). 
If  most IFs function in part to provide mechanical integrity 
to cells, then it seems likely that genetic defects in other IF 
genes might lead to cell fragility and degeneration in other 
tissues, as suggested above. However, it is also expected that 
the mechanical strength requirements of a cell will vary dra- 
matically, depending on its shape and environment. In fact, 
when D-M  EBS keratinocytes are flattened either during 
wound healing in vivo or on a petri dish in vitro, lysis is re- 
duced (21). Moreover, K8 and K18 seem to be essential in 
Xenopus gastrulation (38, 63) and in liver development (6), 
but not in early mouse development (5, 6), a finding that is 
difficult to explain without invoking either (a) tissue and 
developmental-specific differences in mechanical strength 
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present  remain  obscure.  In  the  future,  elucidating  the 
specialized requirements of cells and tissues for IFs will be 
paramount in determining  the extent to which defects in the 
'~50 human IF genes might give rise to a broad family  of 
diseases, which may even extend beyond degenerative  dis- 
orders. 
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